2ZQ-33393-13698
3 vaccinations
2 coded responses
18 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 840 / UT
- Registered
- 2021-04-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-31
Dose 1 — Pfizer-BioNTech
-
2021-04-21
Registered in v-safe
-
2021-04-21
Dose 2 — Pfizer-BioNTech
- 2021-04-21
-
2021-04-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-05-05
- 2021-05-12
- 2021-05-19
- 2021-05-26
- 2021-06-04
- 2021-07-21
- 2021-10-20
-
2021-11-20
Dose 3 — Pfizer-BioNTech
- 2022-04-21
-
2022-05-21
Survey response — 6 months, dose 3MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: GoodFree text: Seasonal colds. Tested for covid and they were negative.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-20
Survey response — 12 months, dose 3MedDRA: Breast cancer, COVID-19, Delivery — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Had a baby (July 2022), diagnosed with breast cancer (June 2022), got covid twice (Aug 2022, Oct 2022)MedDRA releases: 2024-11 · check-in free text available
-
2022-11-20
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-11-21
Call successfulNot applicable - Accidental Reporting
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-31 | Pfizer-BioNTech | |
| 2 | 2021-04-21 | Pfizer-BioNTech | |
| 3 | 2021-11-20 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-11-20 | Successful 2022-11-21 |
Not applicable - Accidental Reporting |
Free text
Release 11 — 6 months, dose 3
Symptoms: Seasonal colds. Tested for covid and they were negative.
Release 12 — 12 months, dose 3
Symptoms: Had a baby (July 2022), diagnosed with breast cancer (June 2022), got covid twice (Aug 2022, Oct 2022)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Breast cancer | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Delivery | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release